UK Science Budget

Graham Stringer Excerpts

Wednesday 21st October 2015 Westminster Hall

[Stuart Andrew]

I am grateful for that intervention. I think I should have applied for a longer debate, given the number of Members who are here. As a fellow Yorkshire MP, and given the importance of the agri-food industry for our county, I certainly agree with my hon. Friend’s points.

Groups such as Universities UK are concerned that, while the Government have made a commitment of capital expenditure for the forthcoming spending period, they have yet to make any commitment of revenue expenditure, which would allow the sector to make the best use of both new and existing facilities and infrastructure. What will we lose if the Government do not maintain their commitment? Frankly, if we have less, clearly we can do less. The UK science sector has been very good at making efficiencies, through equipment sharing and team science, but there is a finite amount of adjustment that it can make, and further cuts will have a damaging impact on the ability of the sector to conduct world-class research.

[Graham Stringer (Blackley and Broughton) (Lab)]

The hon. Gentleman is being generous with his time in this short debate. He makes a good case about the quality and high impact of United Kingdom science, but does he agree that the target that the Government should really set is to increase the amount of money we spend on science above the 1.8% of GDP that we spend at the moment, and to bring it much closer to 3% of GDP? That is the European Union’s international standard, and some of our competitors are heading in that direction very quickly.

[Stuart Andrew]

I fear that the hon. Gentleman has just ruined the end of my speech, but it will be worth emphasising the point.

The goal of eliminating the deficit is, of course, necessary, but some universities have already felt the effect of funding reductions. Any further reductions would, in the Russell Group’s words, be

“entirely counterproductive for the long-term health of the economy and risk losing the UK’s competitive advantage”.

The benefits of research are not a secret. We are not the only country that has realised that research is a worthwhile investment. Other countries are substantially increasing their support for research and development. If we are unable to maintain our world-leading reputation, we risk falling behind and losing talent and business overseas, or to different sectors altogether. We saw that in the 1980s, when cuts in research drove many UK scientists to the USA. We do not want that to happen again.

We still have further to go. Cardiovascular disease causes more than a quarter of all deaths in the UK, and the cost of premature death, lost productivity, hospital treatment and prescriptions relating to cardiovascular disease is estimated at £15 billion to £19 billion each year. We have made huge improvements to our health and wellbeing, but our successes bring with them new challenges. When I worked in the children’s hospice movement I saw many times how children with complex and once fatal conditions now survive into adulthood; we must discover how to keep them healthy throughout their lives. As people live longer, we need to learn how to manage chronic conditions, so that we are not only extending but improving life.

Scientific research has brought us a long way in improving the health and wealth of the UK. Through continued Government investment, maintained in line with inflation, we can build on the successes that have been achieved so far and work towards a UK that realises its full potential. Universities UK has suggested, as did the hon. Member for Blackley and Broughton (Graham Stringer), that we should seek to match the level of expenditure of our competitor countries; otherwise there is a risk that our relative research strength will decline. Using the same group of comparator countries identified in a recent benchmarking study conducted on behalf of the Department for Business, Innovation and Skills, the overall investment level required would be 2.9% of GDP. That level of total investment would also be broadly consistent with the commitment made in the Lisbon treaty for investment across the European Union of 3%, with one third coming from public sources. To support that overriding objective, the Government should set out a 10-year investment strategy, with a view to securing an above-inflation rise in public investment in science and research over that period. That would help to maintain our reputation across the globe, and our lead in so many fields which will improve all our lives.